Sitagliptin, Vildagliptin, Anagliptin, Saxagliptin, and Alogliptin are the main clinically used chemicals for human dipeptidyl peptidase-4 (DPP4) inhibition despite their side effects as pancreatitis, nausea, and anemia [31]. Here, DPP4 is linked to anemia (phenotype).